Loading clinical trials...
Loading clinical trials...
A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia
Conditions
Interventions
Psilocybin
Psychotherapy
Locations
1
United States
Chronic Pain and Fatigue Research Center
Ann Arbor, Michigan, United States
Start Date
September 27, 2023
Primary Completion Date
June 12, 2024
Completion Date
June 12, 2024
Last Updated
April 16, 2025
NCT05901259
NCT03759522
NCT07186751
NCT06574165
NCT06157866
NCT05067998
Lead Sponsor
Kevin Boehnke
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions